Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
75.5M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
18.7M
-
Shares change
-
+1.83M
-
Total reported value, excl. options
-
$134M
-
Value change
-
+$13M
-
Number of buys
-
30
-
Number of sells
-
-5
-
Price
-
$7.14
Significant Holders of Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) as of Q2 2020
43 filings reported holding GRTX - Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q2 2020.
Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.7M shares
of 75.5M outstanding shares and own 24.81% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.36M shares), NOVO Holdings A/S (3.41M shares), Sofinnova Investments, Inc. (3.08M shares), Blackstone Group Inc (1.68M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.51M shares), Tekla Capital Management LLC (1.04M shares), RA CAPITAL MANAGEMENT, L.P. (825K shares), Rock Springs Capital Management LP (568K shares), SPHERA FUNDS MANAGEMENT LTD. (469K shares), and BlackRock Inc. (397K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.